ABT
Abbott Laboratories$108.89
ABT info-0.20%ย โ€ข 24 H
Dividend Yield:1.7%
Global Rank#59
Market Cap$189.23B
YTD Performance-0.61%
P/E27.85
Revenue$43.65B
Change 7d-2.09%
SP500 BenchmarkUnderperform
P/S4.33
Earnings$6.93B

Abbott Laboratories (ABT) Stock Overview

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Mรฉniรจre's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

ABT Stock Information

SymbolABT
Address
100 Abbott Park RoadNorth Chicago, IL 60064-6400United States
Founded-
Trading hours9:30 AM - 4:00 PM ET
Websitehttps://www.abbott.com
Country๐Ÿ‡บ๐Ÿ‡ธ United States
Phone Number224 667 6100

Abbott Laboratories (ABT) Price Chart

-
Value:-

Abbott Laboratories Overview: Key Details and Summary

Stock data
2022
Change
Price
$108.89
N/A
Market Cap
$189.23B
N/A
Shares Outstanding
1.74B
-1.49%
Employees
115.00K
N/A
Shareholder Equity
36.91B
2.45%
Valuation
2022
Change
P/E Ratio
27.85
N/A
P/S Ratio
4.33
N/A
P/B Ratio
5.13
N/A
P/FCF
24.25
N/A
POE
0.00
N/A
Dividends
2022
Change
Dividend Yield
1.75%
N/A
Dividend per share
1.9041
N/A
Dividend Payout Ratio
0.4773
N/A
Growth
2022
Change
ROIC
0.1569
N/A
WACC
0.0150
N/A
CAPEX
-1.78B
N/A
Return on Equity
0.1879
N/A
Earnings
2022
Change
Revenue
$43.65B
N/A
Earnings
$6.93B
N/A
Free Cash Flow
$7.80B
N/A
EPS
3.91
N/A
Earnings Yield
0.0359
N/A
Gross Margin
0.5615
N/A
Operating Margin
0.1916
N/A
Net income margin
0.1588
N/A
FCF Margin
0.1788
N/A
Financial Strength
2022
Change
Total Assets
$74.44B
N/A
Total Debt
$17.72B
N/A
Cash on Hand
$10.17B
N/A
Debt to Equity
$1.02
-6.47%
Cash to Debt
0.5741
6.45%
POE
0.0000
N/A
Current Ratio
$1.63
-11.95%
Other data
2022
Change
Buyback Yield
0.0201
N/A
ยฉ 2024 TopStocks.org
Facebook Icon
Twitter Icon
Linkedin Icon